Clinical Trials Directory

Trials / Sponsors / Sumitomo Pharma (Suzhou) Co., Ltd.

Sumitomo Pharma (Suzhou) Co., Ltd.

Industry · 13 registered clinical trials.

StatusTrialPhaseStarted
TerminatedThe Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From Olanzapine
Schizophrenia
Phase 42021-12-30
CompletedThe Safety and Efficacy of Lurasidone With Different Initiation Dose in Chinese Acute Phase Patients With Schi
Schizophrenia
Phase 42021-08-16
TerminatedA Study of Lurasidone Compared With Placebo for the Treatment of Bipolar I Depression
Bipolar I Depression
Phase 32020-12-11
CompletedThe Safety and Effectiveness of Latuda® Post-marketing Surveillance in the Treatment of Chinese Schizophrenia
Schizophrenia
—2020-12-01
TerminatedEffects on Social and Cognition Functions of Blonanserin in First Episode Schizophrenia Patients
First Episode Schizophrenia, Social Function, Cognition Function
Phase 42019-01-22
CompletedEfficacy and Safety of Arotinolol Hydrochloride on Morning Blood Pressure and Heart Rate
Essential Hypertension
Phase 42015-08-01
CompletedPharmacokinetic Study of Lurasidone After Multiple Oral Administration in Healthy Human Subjects
Schizophrenia
Phase 12014-04-01
CompletedA Pharmacokinetic Study of Lurasidone After Single Oral Administration in Healthy Subjects
Schizophrenia
Phase 12014-03-01
CompletedA Clinical Trial of Lurasidone in Treatment of Schizophrenia
Schizophrenia
Phase 32013-12-01
CompletedEfficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone
Schizophrenia
Phase 32012-02-01
CompletedTandospirone Citrate in the Treatment of Patients With Generalized Anxiety Disorder
Generalized Anxiety Disorder
Phase 42012-01-10
CompletedEffect of Arotinolol Hydrochloride on Cardiovascular Events in Hypertensive Haemodialysis Patients
Chronic Kidney Disease
Phase 42011-04-01
CompletedPhase3 Study of Amrubicin With Cisplatin Versus Etoposide-cisplatin for Extensive Disease Small Cell Lung Canc
Lung Cancer
Phase 32008-04-01